Study shows that a new experimental cancer drug delays breast tumor growth

June 5th, 2012 - 7:05 pm ICT by Aishwarya Bhatt  

New York, June 5 (THAINDIAN NEWS) A study has shown that an experimental breast cancer drug which has been produced by Roche Holding can slow down the growth of a breast cancer tumors.

The drug, named T-DM1, is a combination of another cancer drug developed by Roche, Herceptin, with a chemotherapy drug.

Chemotherapy drugs, as well as the high levels of radiation currently used as part of chemotherapy treatments, kill cancer cells in human being but they also potentially injure healthy cells. In the last State of Union speech, the US president Barack Obama encouraged US research laboratories to find new medical treatments that can destroy the cancer cells in the human body, without annihilating healthy ones.

The finding of the study will be presented at the American Society of Clinical Oncology, at the annual meeting of the organization, which will take place next Sunday.

Roche is currently planning to file an application with the American Food and Drug Administration and other health regulators for T-DM1 before the of 2012.

The news arrive after other study, carried out by Ireland’s Department of Pharmacology and Therapeutics at TCD, has shown that aspirin reduces the chances of a woman of dying from breast cancer.

Related Stories

Tags: , , , , , , , , , , , , , , , , , , ,

Posted in Health |

Subscribe